Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:07 PM
Ignite Modification Date: 2025-12-24 @ 1:07 PM
NCT ID: NCT00674661
Description: None
Frequency Threshold: 2
Time Frame: 3 months
Study: NCT00674661
Study Brief: Corneal Collagen Cross-Linking for Ectasia (CXL)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Corneal Collagen Cross-linking (CXL) Treatment Group riboflavin ophthalmic solution and UVA irradiation (365 nm at an irradiance of 3 mW/cm2) for 30 minutes None None 1 67 59 67 View
Control Group riboflavin opthalmic solution without UVA irradiation None None 0 63 21 63 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Corneal epithelium defect NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Corneal abrasion SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (Unspecified) View
Corneal opacity SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Eye pain SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Corneal epithelium defect SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Punctate keratitis SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Dry eye SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Photophobia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Vision blurred SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Eye irritation SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Visual acuity reduced SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Corneal striae SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Lacrimation increased SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Ocular discomfort SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Conjunctival hyperaemia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Eyelid oedema SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
anterior chamber flare SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Foreign body sensation in eyes SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
keratitis SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Meibomian gland dyisfunction SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Ocular hyperaemia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Visual impairment SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Anterior chamber cell SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Asthenopia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Corneal oedema SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Glare SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Halo vision SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View